Kosaka M - Search Results

1

Molecular cloning and characterization of a surface antigen preferentially overexpressed on multiple myeloma cells.

Ohtomo T, Sugamata Y, Ozaki Y, Ono K, Yoshimura Y, Kawai S, Koishihara Y, Ozaki S, Kosaka M, Hirano T, Tsuchiya M. Ohtomo T, et al. Among authors: kosaka m. Biochem Biophys Res Commun. 1999 May 19;258(3):583-91. doi: 10.1006/bbrc.1999.0683. Biochem Biophys Res Commun. 1999. PMID: 10329429

2

Antitumor activity of humanized monoclonal antibody against HM1.24 antigen in human myeloma xenograft models.

Kawai S, Yoshimura Y, Iida S, Kinoshita Y, Koishihara Y, Ozaki S, Matsumoto T, Kosaka M, Yamada-Okabe H. Kawai S, et al. Among authors: kosaka m. Oncol Rep. 2006 Feb;15(2):361-7. Oncol Rep. 2006. PMID: 16391855

3

Humanized anti-HM1.24 antibody mediates myeloma cell cytotoxicity that is enhanced by cytokine stimulation of effector cells.

Ozaki S, Kosaka M, Wakahara Y, Ozaki Y, Tsuchiya M, Koishihara Y, Goto T, Matsumoto T. Ozaki S, et al. Among authors: kosaka m. Blood. 1999 Jun 1;93(11):3922-30. Blood. 1999. PMID: 10339501 Free article.

4

The humanized anti-HM1.24 antibody effectively kills multiple myeloma cells by human effector cell-mediated cytotoxicity.

Ono K, Ohtomo T, Yoshida K, Yoshimura Y, Kawai S, Koishihara Y, Ozaki S, Kosaka M, Tsuchiya M. Ono K, et al. Among authors: kosaka m. Mol Immunol. 1999 Apr;36(6):387-95. doi: 10.1016/s0161-5890(99)00029-2. Mol Immunol. 1999. PMID: 10444002

5

Construction of a conventional non-radioisotope method to quantify HM1.24 antigens: correlation of HM1.24 levels and ADCC activity of the humanized antibody against HM1.24.

Kawai S, Koishihara Y, Iida S, Ozaki S, Matsumoto T, Kosaka M, Yamada-Okabe H. Kawai S, et al. Among authors: kosaka m. Leuk Res. 2006 Aug;30(8):949-56. doi: 10.1016/j.leukres.2005.11.023. Epub 2006 Feb 13. Leuk Res. 2006. PMID: 16473407

6

Interferon-alpha enhances CD317 expression and the antitumor activity of anti-CD317 monoclonal antibody in renal cell carcinoma xenograft models.

Kawai S, Azuma Y, Fujii E, Furugaki K, Ozaki S, Matsumoto T, Kosaka M, Yamada-Okabe H. Kawai S, et al. Among authors: kosaka m. Cancer Sci. 2008 Dec;99(12):2461-6. doi: 10.1111/j.1349-7006.2008.00968.x. Epub 2008 Nov 20. Cancer Sci. 2008. PMID: 19032371 Free PMC article.

7

Immunotherapy of multiple myeloma with a monoclonal antibody directed against a plasma cell-specific antigen, HM1.24.

Ozaki S, Kosaka M, Wakatsuki S, Abe M, Koishihara Y, Matsumoto T. Ozaki S, et al. Among authors: kosaka m. Blood. 1997 Oct 15;90(8):3179-86. Blood. 1997. PMID: 9376601 Free article.

8

Multiple myeloma: new aspects of biology and treatment.

Ozaki S, Kosaka M. Ozaki S, et al. Among authors: kosaka m. J Med Invest. 1998 Feb;44(3-4):127-36. J Med Invest. 1998. PMID: 9597800 Review.

9

Generation of potent antitumor CTL from patients with multiple myeloma directed against HM1.24.

Rew SB, Peggs K, Sanjuan I, Pizzey AR, Koishihara Y, Kawai S, Kosaka M, Ozaki S, Chain B, Yong KL. Rew SB, et al. Among authors: kosaka m. Clin Cancer Res. 2005 May 1;11(9):3377-84. doi: 10.1158/1078-0432.CCR-04-0650. Clin Cancer Res. 2005. PMID: 15867238

10

Localization and imaging of human plasmacytoma xenografts in severe combined immunodeficiency mice by a new murine monoclonal antibody, anti-HM1.24.

Ozaki K, Ozaki S, Kosaka M, Saito S. Ozaki K, et al. Among authors: kosaka m. Tokushima J Exp Med. 1996 Jun;43(1-2):7-15. Tokushima J Exp Med. 1996. PMID: 8885684

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

457 results

Search Page

Filters